The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to evaluating the safety and efficacy of nicotine replacement therapy (NRT) products, including how they should be used and labeled.
Document
The Food and Drug Administration's Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to evaluating the safety and efficacy of nicotine replacement therapy (NRT)...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 56759
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“The Food and Drug Administration's Approach To Evaluating Nicotine Replacement Therapies; Public Hearing; Request for Comments,” thefederalregister.org (November 30, 2017), https://thefederalregister.org/documents/2017-25671/the-food-and-drug-administration-s-approach-to-evaluating-nicotine-replacement-therapies-public-hearing-request-for-comm.